Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

[1]  M. Solmi,et al.  Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort study , 2022, World psychiatry : official journal of the World Psychiatric Association.

[2]  Tao Liu,et al.  Unsaturated fatty acids in mental disorders: An umbrella review of meta-analyses. , 2022, Advances in Nutrition.

[3]  S. Faraone,et al.  Association between ADHD and vision problems. A systematic review and meta-analysis , 2022, Molecular Psychiatry.

[4]  W. Cubała,et al.  Commentary concerning treatment of depression in patients with heart failure according to 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2022, European journal of preventive cardiology.

[5]  P. Lichtenstein,et al.  The role of ADHD genetic risk in mid-to-late life somatic health conditions , 2022, Translational Psychiatry.

[6]  C. Correll,et al.  Associations between mental and physical conditions in children and adolescents: An umbrella review , 2022, Neuroscience & Biobehavioral Reviews.

[7]  L. Snetselaar,et al.  Association of Food Allergy, Respiratory Allergy, and Skin Allergy with Attention Deficit/Hyperactivity Disorder among Children , 2022, Nutrients.

[8]  S. Bölte,et al.  Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis , 2021, Psychological Medicine.

[9]  I. V. Van Gelder,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[10]  Marina De Vos,et al.  Longitudinal Associations Between Symptoms of ADHD and BMI From Late Childhood to Early Adulthood , 2021, Pediatrics.

[11]  E. Bandak,et al.  Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials , 2021, Nutrients.

[12]  York Hagmayer,et al.  Physical Activity Improves Mental Health in Children and Adolescents Irrespective of the Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD)—A Multi-Wave Analysis Using Data from the KiGGS Study , 2021, International journal of environmental research and public health.

[13]  Steffen E. Petersen,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2016, European journal of preventive cardiology.

[14]  Xue-Ni Xie,et al.  Global prevalence of obesity, overweight and underweight in children, adolescents and adults with autism spectrum disorder, attention‐deficit hyperactivity disorder: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[15]  B. Franke,et al.  Genome-Wide DNA Methylation Patterns in Persistent Attention-Deficit/Hyperactivity Disorder and in Association With Impulsive and Callous Traits , 2020, Frontiers in Genetics.

[16]  A. Rothenberger,et al.  Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study , 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[17]  F. Baumgarten,et al.  ADHS bei Kindern und Jugendlichen in Deutschland – Querschnittergebnisse aus KiGGS Welle 2 und Trends , 2018 .

[18]  S. Mahmoud,et al.  Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children , 2018, Journal of obesity.

[19]  S. Avcil Association between altered lipid profiles and attention deficit hyperactivity disorder in boys , 2018, Nordic journal of psychiatry.

[20]  B. Kurth Editorial: Neues von und über KiGGS , 2018 .

[21]  T. Lampert,et al.  Messung des sozioökonomischen Status und des subjektiven sozialen Status in KiGGS Welle 2 , 2018 .

[22]  A. S. Rosario,et al.  KiGGS Wave 2 longitudinal component – data collection design and developments in the numbers of participants in the KiGGS cohort , 2018, Journal of health monitoring.

[23]  C. Pariante,et al.  Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis of Clinical Trials and Biological Studies , 2018, Neuropsychopharmacology.

[24]  P. Brambilla,et al.  The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD , 2017, International journal of molecular sciences.

[25]  C. Poethko-Müller,et al.  Neue Daten für Taten.Die Datenerhebung zur KiGGS Welle 2 ist beendet , 2017 .

[26]  T. Banaschewski,et al.  Attention-Deficit/Hyperactivity Disorder. , 2017, Deutsches Arzteblatt international.

[27]  C. Pariante,et al.  Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies , 2017 .

[28]  Jan K. Buitelaar,et al.  Attention-deficit/hyperactivity disorder , 2015, Nature Reviews Disease Primers.

[29]  A. Rothenberger,et al.  Erratum to: Six years ahead: a longitudinal analysis regarding course and predictive value of the Strengths and Difficulties Questionnaire (SDQ) in children and adolescents , 2015, European Child and Adolescent Psychiatry.

[30]  A. Rothenberger,et al.  Six years ahead: a longitudinal analysis regarding course and predictive value of the Strengths and Difficulties Questionnaire (SDQ) in children and adolescents , 2015, European Child & Adolescent Psychiatry.

[31]  J. Nigg,et al.  Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. , 2014, Clinical psychology review.

[32]  A. Thapar,et al.  Practitioner Review: What have we learnt about the causes of ADHD? , 2013, Journal of Child Psychology and Psychiatry, and Allied Disciplines.

[33]  K. Lesch,et al.  A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms , 2011, Expert review of neurotherapeutics.

[34]  J. Thome,et al.  Modified magnesium and lipoproteins in children with attention deficite hyperactivity disorder (ADHD) , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[35]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[36]  T. Banaschewski,et al.  Psychometric Validity of the Strengths and Difficulties Questionnaire-Dysregulation Profile , 2010, Psychopathology.

[37]  Nehemia Kaysar,et al.  Methylphenidate Has Positive Hypocholesterolemic and Hypotriglyceridemic Effects: New Data , 2009, Journal of clinical pharmacology.

[38]  B. Kurth,et al.  How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS) , 2008, European Child & Adolescent Psychiatry.

[39]  A. Berg,et al.  Frequency of secondary dyslipidemia in obese children , 2008, Vascular health and risk management.

[40]  Gert B. M. Mensink,et al.  The challenge of comprehensively mapping children's health in a nation-wide health survey: Design of the German KiGGS-Study , 2008, BMC public health.

[41]  B. Horta,et al.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.

[42]  C. Scheidt-Nave,et al.  Biochemische Messparameter im Kinder- und Jugendgesundheitssurvey (KiGGS) , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[43]  H. Hölling,et al.  Der Kinder- und Jugendgesundheitssurvey (KiGGS): Studienmanagement und Durchführung der Feldarbeit , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[44]  B. Kurth Der Kinder- und Jugendgesundheitssurvey (KiGGS): Ein Überblick über Planung, Durchführung und Ergebnisse unter Berücksichtigung von Aspekten eines Qualitätsmanagements , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[45]  H. Knopf,et al.  Arzneimittelanwendung bei Kindern und Jugendlichen , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[46]  B. Kurth [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): an overview of its planning, implementation and results taking into account aspects of quality management]. , 2007, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[47]  B. Kurth Symposium zur Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland , 2006, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[48]  S. Chalon Omega-3 fatty acids and monoamine neurotransmission. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[49]  Aneeq Ahmad,et al.  Decrease in neuron size in docosahexaenoic acid-deficient brain. , 2002, Pediatric neurology.

[50]  H. Meltzer,et al.  Lower serum high‐density lipoprotein cholesterol (HDL‐C) in major depression and in depressed men with serious suicidal attempts: relationship with immune‐inflammatory markers , 1997, Acta psychiatrica Scandinavica.

[51]  P. Cowen,et al.  Low Serum Cholesterol and Suicide , 1993, British Journal of Psychiatry.

[52]  H. Engelberg,et al.  Low serum cholesterol and suicide , 1992, The Lancet.

[53]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .